Drug
Inosine clinical trials
Includes 1 study of Inosine glycyl-cysteinyl-glutamate disodium.
- studies test it
- 12
- open now
- 2
- in phase 3
- 3
- first study started
- 2002
Keep track of what changes. Save the Inosine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2009 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 5
- Phase 3
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 12
Massachusetts General Hospital (2) · Michael Alan Schwarzschild (2) · Fudan University (1) · University Hospital, Basel, Switzerland (1) · Beijing Friendship Hospital (1) · The Parkinson Study Group (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · Superficial Siderosis Research Alliance Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Inosine is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Phase Ib Trial of Combined Febuxostat and Inosine Therapy in Patients With Parkinson's DiseaseRecruitingPhase 1Fujita Health UniversityNCT07170475Written as Inosine
- Therapeutic Antioxidant SupplementationNot yet recruitingNot applicableSuperficial Siderosis Research Alliance Inc.NCT04890808Written as Inosine
- Inosine Reverse Chemo Resistance in Triple Negative Breast CancerCompletedPhase 2Fudan UniversityNCT06355024Written as Inosine
- Inosine Energy Expenditure StudyCompletedNot applicableUniversity Hospital, Basel, SwitzerlandNCT04476238Written as Inosine
- Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid TumorsCompletedPhase 2/3Beijing Friendship HospitalNCT05809336Written as Inosine 0.2g orally 3 times/day
- Clinical Study in the Treatment of Patients With COVID-19Status unknownPhase 3Pharma VAMNCT04780672Written as Molixan
- Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 2Massachusetts General HospitalNCT03168711Written as Inosine
- Study of Urate Elevation in Parkinson's Disease, Phase 3CompletedPhase 3Michael Alan SchwarzschildNCT02642393Written as Inosine
- A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)CompletedPhase 1Massachusetts General HospitalNCT02288091Written as Inosine
- A Food-Drug Interaction Study of Serum Urate After Oral InosineCompletedPhase 1Michael Alan SchwarzschildNCT02614469Written as Inosine
- Safety of Urate Elevation in Parkinson's DiseaseCompletedPhase 2The Parkinson Study GroupNCT00833690Written as inosine
- Treatment of Multiple Sclerosis Using Over the Counter InosineCompletedPhase 2National Center for Complementary and Integrative Health (NCCIH)NCT00067327Written as Inosine
Codes
What other systems call Inosine · ClinicalTrials.gg INT007661
- MeSH (NLM) D007288InosineConfirmed NLM, Wikidata
- UNII (FDA) 5A614L51CTINOSINEConfirmed FDA, NLM, Wikidata
- RxNorm 1483575Confirmed FDA, Wikidata
- Wikidata Q422564inosineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166836InosineOne source FDA
- DrugBank DB04335One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007288 | Inosine | Confirmed NLM, Wikidata |
| UNII (FDA) | 5A614L51CT | INOSINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1483575 | — | Confirmed FDA, Wikidata |
| Wikidata | Q422564 | inosine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166836 | Inosine | One source FDA |
| DrugBank | DB04335 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.